CIK 0001410098
- Non-accelerated filer
CorMedix Inc.
Sign in to watch- Ticker
- CRMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 908-517-9500
- Business address
- 389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NJ, 07054
- 4 Shares withheld for taxes Chief Commercial Officer gave up 4,389 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 13,781 shares (to pay taxes)
- 4 Open-market buy Director bought 6,000 shares at an average $3.38 ($20,250)
- 4 Grant or award Chief Legal Officer acquired 50,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Commercial Officer bought 1,000 shares at $4.00 ($4,000)
- 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $3.71 ($37,100)
- 4 Open-market buy Director bought 6,000 shares at $4.54 ($27,258)
- 4/A Open-market buy Director bought 10,000 shares at $4.65 ($46,500)
- 4/A Open-market buy Director bought 3,000 shares at $4.33 ($12,980)
- 4/A Open-market buy Director bought 10,000 shares at $4.37 ($43,735)
- 4/A Open-market buy Chief Executive Officer bought 5,000 shares at $4.58 ($22,900)
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 4 Grant or award Director acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 5,000 shares (grant or award)
- 4 Shares withheld for taxes Chief Executive Officer gave up 37,443 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 5 of 26 · 513 filings